ALPHARETTA, Ga. , Oct. 30, 2024 /PRNewswire/ -- Avanos Medical, Inc.
(NYSE: AVNS ) today reported third quarter 2024 financial results and announced the retirement of its CEO, Joe Woody . Gary Blackford , Avanos Board Chairman, noted, "Joe has decided to retire after leading Avanos for the past seven years. Joe has agreed to assist the Company in the transition of leadership, and will continue to consult with the Company through April of next year.
Avanos is better positioned financially and organizationally today to achieve its longer-term value creation goals because of Joe's leadership these past seven years and we thank him." Blackford continued, "We are also pleased to announce that Michael Greiner has agreed to serve as interim CEO for Avanos. As Avanos' CFO and Chief Transformation Officer, Michael has demonstrated his ability to deliver consistent results against our three-year transformation plan and he is well positioned to step in as interim CEO.
" Third Quarter 2024 Financial Highlights Total net sales from continuing operations were $170.4 million , a 0.5% decrease from the comparable prior year period.
Net income from continuing operations was $5.9 million , compared to net loss from continuing operations of $8.8 million a year ago.
Adjusted net income from continuing operations totaled $16.7 million , compared to $14.0 million a year ago.
Diluted earnings per share from continuing operations was $0.12 , compared to diluted loss per share of $0.19 a year ago.
Adj.
